Applied Biosystems/MDS Analytical Technologies Introduces Next-Generation Mass Spectrometry Systems
Danaher Corporation (NYSE: DHR) today announced that it has signed a definitive agreement with MDS Inc. (TSX: MDS; NYSE: MDZ) to acquire the Analytical Technologies division of MDS, which includes a 50% ownership position in Applied Biosystems/MDS Sciex joint venture ("SCIEX"), a mass spectrometry business, and a 100% ownership position in the former Molecular Devices Corporation, a bioresearch and analytical instrumentation company.
U.S. Food and Drug Administration Selects Applied Biosystems to Provide Mass Spectrometry Instrument Systems for Food Contaminant Testing
Applied Biosystems Inc. (NYSE:ABI) today announced that the U.S. Food and Drug Administration has purchased seven of the company's 4000 QTRAP(R) Systems for the analysis of potential harmful pesticides in the U.S. food supply.
Scientific Collaboration Seeks to Develop New Methods to Better Identify Contaminants in Drinking Water
A team of scientists representing academia and industry are collaborating to improve the identification of contaminants in drinking water.
Applied Biosystems/MDS Analytical Technologies to Demonstrate Productivity Solutions at International Mass Spectrometry Conference
Mass spectrometry, which was until recently a complicated technology available exclusively to highly trained experts, is today a workhorse analytical technique for a wide variety of scientific applications including basic research, drug discovery and development, food and environmental contamination testing and forensic analysis.